(203 days)
The PhotoGenica YLV laser is used for the treatment of benign cutaneous vascular and vascular dependent lesions.
Not Found
I am sorry, but based on the provided text, there is no information about the acceptance criteria or a study that proves the device meets specific acceptance criteria. The document is a clearance letter from the FDA for a device called "Cynosure PhotoGenica VLV Cutaneous Vascular Lesion Laser," indicating that it has been determined to be substantially equivalent to devices marketed prior to May 28, 1976.
The letter mentions:
- Trade Name: Cynosure PhotoGenica VLV Cutaneous Vascular Lesion Laser
- Regulatory Class: II
- Product Code: GEX
- Indications For Use: The PhotoGenica YLV laser is used for the treatment of benign cutaneous vascular and vascular dependent lesions.
However, it does not include details on:
- A table of acceptance criteria and reported device performance.
- Sample size used for the test set or data provenance.
- Number of experts used to establish ground truth or their qualifications.
- Adjudication method for the test set.
- MRMC comparative effectiveness study or effect size.
- Standalone performance study.
- Type of ground truth used.
- Sample size for the training set.
- How ground truth for the training set was established.
This document serves as an FDA clearance notification rather than a detailed technical report or study summary.
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.